SEARCH

SEARCH BY CITATION

References

  • 1
    Van Boxel JA, Paget SA: Predominantly T-cell infiltrate in rheumatoid synovial membrane. N Engl J Med 293: 517520, 1975
  • 2
    Duke O, Panayi GS, Janossy G, Poulter LW: An immunohistological analysis of lymphocyte subpopulations and their micro-environment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 49: 2230, 1982
  • 3
    Stamenkovic I, Stegagno M, Wright KA, Krane SM, Amento EP, Colvin RB, Duquesnoy RJ, Kurnick JT: Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A 85: 11791183, 1988
  • 4
    Stastny P: Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298: 869871, 1978
  • 5
    Janeway CA, Haque S, Smith LA, Saizawa K: The role of the murine L3T4 molecule in T cell activation:differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies. J Mol Cell Immunol 3: 121131, 1987
  • 6
    Wofsy D, Seaman WE: Successful treatment of autoimmunity in NZB-NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161: 378391, 1985
  • 7
    Wofsy D, Seaman WE: Reversal of advanced murine lupus in NZB-NZW F1 mice by treatment with monoclonal antibody to L3T4. J Immunol 138: 32473253, 1987
  • 8
    Herzog C, Walker C, Pichler W, Aeschlimann A, Wassmer P, Stockinger H, Knapp W, Rieber P, Müller W: Monoclonal anti-CD4 in arthritis. Lancet II: 14611462, 1987
  • 9
    Horneff G, Burmester GR, Emmrich F, Kalden JR: Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 34: 129140, 1991
  • 10
    Wendling D, Wijdenes J, Racadot E, Morel-Fourrier B: Therapeutic use of monoclonal anti CD4 antibody in rheumatoid arthritis. J Rheumatol 18: 325327, 1991
  • 11
    Reiter C, Kakavand B, Rieber EP, Schattenkirchner M, Riethmüller G, Krüger K: Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151:clinical results and immunopharmacologic effects in an open study, including repeated administration. Arthritis Rheum 34: 525536, 1991
  • 12
    LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB: Mouse-human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci U S A 86: 42204224, 1989
  • 13
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315324, 1988
  • 14
    Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659662, 1949
  • 15
    Ritchie DM, Boyle JA, Mclnnos JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 147: 393406, 1968
  • 16
    Lee P, Jasani MK, Dick WC, Buchanan WW: Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol 2: 7177, 1973
  • 17
    Benjamin R, Waldmann H: Induction of tolerance by monoclonal antibody therapy. Nature 320: 449451, 1986